- 1. 3-AP/Cisplatin/Paclitaxel
- (UMLS (NCI) C0935830) =Therapeutic or Preventive Procedure
| - 51. API An-IDENT
- [Identification, API An-IDENT ( HL7V3.0 )] (UMLS (HL7) C1553135) =Laboratory Procedure =ObservationMethod;
|
- 2. 3AP/FAMP
- [A combination of the thiosemicarbazone 3-aminopyridine-2-carboxaldehyde (3-AP) and the nucleoside analogue fludarabine with antineoplastic activity. The agents in 3-AP/fludarabine, act synergistically to inhibit the enzyme ribonucleotide reductase.. Composed of two subunits, this enzyme catalyzes the rate-limiting step in the conversion of ribonucleotides to deoxyribonucleotides. The 3-AP binds to and inactivates one subunit while fludarabine binds to and inactivates the other. Fludarabine also inhibits DNA polymerase alpha and DNA primase. At low concentrations, this agent arrests tumor cells in the S-phase of the cell cycle; at higher concentrations, in the G0/G1 phase of the cell cycle. (NCI04) ( NCI )] (UMLS (NCI) C1328164) 3-AP/Fludarabine =Therapeutic or Preventive Procedure; ;
| - 52. API Coryne
- [Identification, API Coryne ( HL7V3.0 )] (UMLS (HL7) C1553136) =Laboratory Procedure =ObservationMethod;
|
- 3. 7a-[9-[(4,4,5,5,5,-Pentafluoropentyl)sulphinyl]nonyl]-estra-1,3,5(10)-triene-3,17b-diol
- [A synthetic estrogen receptor antagonist. Unlike tamoxifen (which has partial agonist effects) and the aromatase inhibitors (which reduce the estrogen available to tumor cells), fulvestrant binds competitively to estrogen receptors in breast cancer cells, resulting in estrogen receptor deformation and decreased estrogen binding. In vitro studies indicate that fulvestrant reversibly inhibits the growth of tamoxifen-resistant, estrogen-sensitive, human breast cancer cell lines. (NCI04) ( NCI )] (UMLS (NCI) C0935916) FULVESTRANT;
FULVESTRANT PREPARATION =Steroid; Pharmacologic Substance ;
=[AN500] ANTINEOPLASTIC HORMONES;
Unclassified Ingredients =FULVESTRANT 50 MG/ML;
| - 53. API Rapid 20E
- [Identification, API Rapid 20E ( HL7V3.0 )] (UMLS (HL7) C1553137) =Laboratory Procedure =ObservationMethod;
|
- 4. A previously unscheduled walk-in visit
- (UMLS (HL7) C1548404) =Intellectual Product =Appointment reason codes;
| - 54. API Staph
- [Identification, API Staph ( HL7V3.0 )] (UMLS (HL7) C1553138) =Laboratory Procedure =ObservationMethod;
|
- 5. A product from a controlled/non-related inventory was evaluated
- (UMLS (HL7) C1546983) =Idea or Concept =Product source;
| - 55. API ZYM
- [Identification, API ZYM ( HL7V3.0 )] (UMLS (HL7) C1553139) =Laboratory Procedure =ObservationMethod;
|
- 6. A product from a reserve sample was evaluated
- (UMLS (HL7) C1546984) =Idea or Concept =Product source;
| - 56. API1
- [This gene is a potent inhibitor of apoptosis and plays an important role in apoptotic signal transduction. ( NCI )] (UMLS (NCI) C1332414) Baculoviral IAP Repeat-Containing 2 Gene;
BIRC2;
BIRC2 Gene =Gene or Genome ;
|
- 7. A product from the same lot as the actual product involved was evaluated
- (UMLS (HL7) C1546982) =Idea or Concept =Product source;
| - 57. API4
- [an anti-apoptosis protein expressed in lymphoma and cancers of lung, colon, pancreas, prostate and breast; potent inhibitor of some caspases. ( CSP )] (UMLS (NCI) C0664336) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=MAP;
Tumor Antigen |
- 8. a-protein
- [HMGA1a is one of three protein products of the same gene, HMGA1, generated by alternative splicing. The HMGA1a protein contains three basic domains, named AT-hooks and an acidic C-terminal region. AT-hooks are responsible for binding to AT-rich sequences inside the minor groove of DNA. Phosphorylation of HMGA1a by both PKC and cdc-2 kinases strongly reduces its DNA binding affinity and is critical in cell cycle progression. HMGA1a activates the interferon-beta gene (IFN-beta) by functioning as the essential architectural component for the assembly and stability of the IFN-beta enhanceosome. (PMID11576996) ( NCI )] (UMLS (NCI) C0038164) =Amino Acid, Peptide, or Protein; Immunologic Factor; Indicator, Reagent, or Diagnostic Aid
| - 58. Apical
- [Relating to or located at the tip (an apex). ( NCI )] (UMLS (NCI) C0205111) =Spatial Concept
|
- 9. AP
- [A pre-filled non-injectable pipette, syringe or tube. ( NCI )] (UMLS (NCI) C0179108) =Medical Device =Administration Device;
Unclassified Ingredients =APPLICATOR POINTED;
| - 59. apical membrane
- [cell membrane found on the surface of vertebrate epithelial cells which faces the external lumen and may be involved in transport of substances across the cell. ( CSP )] (UMLS (CSP) C0596119) =Cell Component ;
=cell membrane;
|
- 10. AP
- (UMLS (NCI) C0279212) =Therapeutic or Preventive Procedure
| - 60. Apical Myocardial Infarction
- (UMLS (NCI) C1168331) =Disease or Syndrome
|
- 11. AP Endonuclease Class I
- [APEX Nuclease, encoded by the APE1 gene, is a ubiquitous monomeric apurinic/apyrimidinic DNA repair endonuclease (AP/EXOA family) with 3-prime-, 5-prime-exonuclease, DNA 3-prime repair diesterase, and DNA 3-prime-phosphatase activities. The constitutive gene contains five exons spanning 2.64 kb; the first exon is untranslated. The 0.5 kb upstream DNA contains only a possible CCAAT box and no other regulatory sites or a TATA box. A potent activator of p53 protein, APE1 may protect against cell lethality and suppress mutations produced by spontaneous hydrolysis, by chemicals and radiation, or by DNA glycosylases that remove abnormal bases from DNA. Abasic sites that can block DNA replication and cause mutations must be corrected to restore genetic integrity. A repressor of the PTH gene, APE binds to promoter negative Ca(2+)-response elements, which are also present in the APE1 gene. ( NCI )] (UMLS (NCI) C0140145) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 61. Apicectomy
- [The surgery involving excision of the apex of the petrous portion of the temporal bone. ( NCI )] (UMLS (NCI) C0003571) =Therapeutic or Preventive Procedure ;
|
- 12. AP-2 Family Protein
- [Activator Protein 2. Originally identified as a cellular transcription factor that binds the enhancer region of SV40. It is encoded by a family of related genes, AP-2 alpha, AP-2 beta, and AP-2 gamma. AP-2 is developmentally regulated and inducible by RET. ( NCI )] (UMLS (NCI) C1332097) AP-2 Family Transcription Factor;
=Amino Acid, Peptide, or Protein; Biologically Active Substance | - 62. Apicoectomy and root canal therapy
- [ ] (UMLS (ICD9CM) C0176403) =Therapeutic or Preventive Procedure
|
- 13. Ap3A Hydrolase
- [FHIT protein is a 147-amino acid AP3A hydrolase. The FHIT preferred substrate, AP3A (diadenosine 5-prime,5-triple prime-P(1),P(3)-triphosphate), and AP4A have been proposed to have various intracellular functions, including regulation of DNA replication and signaling stress responses. (from OMIM) ( NCI )] (UMLS (NCI) C1173495) AP3Aase;
bis(5'-adenosyl)-triphosphatase;
Diadenosine 5',5'''-P1,P3-triphosphate Hydrolase;
Dinucleosidetriphosphatase;
FHIT;
FHIT Protein =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 63. Apicomplexa
- [phylum of protozoa characterized by the presence of complex apical organelles generally consisting of a conoid that aids in penetrating host cells, rhoptries that possibly secrete a proteolytic enzyme, and subpellicular microtubules that may be related to motility. ( CSP )] (UMLS (CSP) C0085316) =Invertebrate ;
=protozoa;
=Babesia;
Coccidia;
Plasmodium;
|
- 14. Apache
- (UMLS (NCI) C0337855) =Population Group =American Indian;
=Chiricahua;
Fort Sill Apache;
Jicarilla Apache;
Lipan Apache;
Mescalero Apache;
Oklahoma Apache;
Payson Apache;
San Carlos Apache;
White Mountain Apache | - 64. APL unit
- [biologic activity of anticardiolipin IgA ( HL7V3.0 )] (UMLS (HL7) C1552996) =Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens |
- 15. Apache Tribe of Oklahoma
- (UMLS (HL7) C1554225) =Population Group =NativeEntityContiguous;
| - 65. Aplastic anemia and other bone marrow failure syndromes
- [ ] (UMLS (ICD9CM) C1719323) =Disease or Syndrome
|
- 16. Apachean
- (UMLS (HL7) C1698047) =Language ;
=Athapaskan;
=Kiowa Apache;
EasternApachean;
WesternApachean;
| - 66. Aplastic Anemia due to Infection
- (UMLS (NCI) C0271912) =Disease or Syndrome
|
- 17. APAF1
- [The APF1 protein functions to activate caspase 9 in the cytochrome c/dATP-dependent apoptotic pathway. (from RefSeq Summary) ( NCI )] (UMLS (NCI) C0664613) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 67. Aplastic Anemia due to Radiation
- (UMLS (NCI) C0472734) =Disease or Syndrome
|
- 18. APAF1
- [This gene is involved in pro-apoptotic regulation through caspase interaction. ( NCI )] (UMLS (NCI) C1332098) APAF1 Gene;
Apoptotic Protease Activating Factor 1 Gene =Gene or Genome ;
| - 68. APLASTIC ANEMIAS NEC
- [ ] (UMLS (ICD9CM) C1955746) Other specified aplastic anemias;
=Disease or Syndrome |
- 19. APAF3
- [Caspase-9 is encoded by the CASP9 Gene. Caspase-9 is the most upstream member of the apoptotic protease cascade that is triggered by cytochrome c and dATP. Caspase-9 and APAF1 bind to each other in the presence of cytochrome c and dATP, an event that leads to caspase-9 activation. Activation of procaspase-9 by APAF1 requires proteolytic cleavage to generate the mature caspase molecule. Activated caspase-9 in turn cleaves and activates caspase-3. APAF1-mediated processing of procaspase-9 occurs at asp315 by an intrinsic autocatalytic activity of procaspase-9 itself. APAF1 can form oligomers and may facilitate procaspase-9 autoactivation by oligomerizing its precursor molecules. Once activated, caspase-9 can initiate a biochemical cascade involving the downstream executioners caspase-3, -6, and -7. Alternative splicing of this gene results in two transcript variants which encode different isoforms. (From LocusLink, OMIM and NCI) ( NCI )] (UMLS (NCI) C0910167) APAF-3;
Apoptotic Protease Activating Factor 3;
Apoptotic Protease MCH-6;
CASP9;
CASP-9;
CASP9 Protein;
Caspase 9, Apoptosis-Related Cysteine Protease;
Caspase-9;
EC 3.4.22.-;
ICE-LAP6;
ICE-Like Apoptotic Protease 6;
MCH6 =Amino Acid, Peptide, or Protein; Enzyme | - 69. APLD
- [An anticancer drug obtained from a marine animal. ( NCI )] (UMLS (NCI) C0388638) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
|
- 20. Apartment
- [A room or suite of rooms designed as a residence and generally located in a building occupied by more than one household used as an element of an address. ( NCI )] (UMLS (NCI) C0457933) =Manufactured Object
| - 70. Aplysia
- [genus of motile gastropods with a poorly developed or missing shell; used in neurobiology studies because it possesses a simple nervous system with large, individually identifiable neurons. ( CSP )] (UMLS (CSP) C0003577) =Invertebrate ;
|
- 21. apatite
- [family of minerals composed of mutilples of Ca5-(PO4)6-OH; one of the 2 major minerals of bones and teeth, the other being calcium carbonate. ( CSP )] (UMLS (CSP) C0003522) =Inorganic Chemical ;
| - 71. Aplysia Ras-Related Homolog 12
- [RHO A GTP-binding protein is involved in regulating signal transduction pathways that control assembly of focal adhesions and actin stress fibers. Rho regulates remodeling of the actin cytoskeleton during cell morphogenesis and motility. Active Rho signals to its downstream effector ROCK1, which phosphorylates and activates LIM kinase. LIM kinase, in turn, phosphorylates cofilin, inhibiting its actin-depolymerizing activity. (from OMIM 165390 and NCI) ( NCI )] (UMLS (NCI) C0084340) =Amino Acid, Peptide, or Protein; Enzyme
|
- 22. APC
- [Ectopic impulses originating in the atria. ( NCI )] (UMLS (NCI) C0033036) =Disease or Syndrome =Cardiac Complexes, Premature;
| - 72. Aplysia RAS-Related Homolog 9
- [RHO C protein is a product of the ARHC gene that regulates remodeling of the actin cytoskeleton during cell morphogenesis and motility. Rho C enhances metastasis when over expressed, whereas a dominant-negative Rho inhibits metastasis. Analysis of the phenotype of cells expressing dominant-negative Rho C indicates that Rho C is important in tumor cell invasion. (from OMIM 165380 and NCI) ( NCI )] (UMLS (NCI) C0084342) =Amino Acid, Peptide, or Protein; Enzyme
|
- 23. APC8015
- [Immune system cells that are collected from a patient with prostate cancer and treated in the laboratory with a molecule found on prostate cells. The treated cells are being studied for their ability to stimulate the immune system to kill prostate cancer cells. ( NCI )] (UMLS (NCI) C0879584) APC8015 Vaccine;
=Pharmacologic Substance; Immunologic Factor ;
| - 73. apnea
- [cessation of breathing. ( CSP )] (UMLS (CSP) C0003578) =Pathologic Function ;
|
- 24. APC8015/Bevacizumab
- (UMLS (NCI) C1134539) =Therapeutic or Preventive Procedure
| - 74. apneustic center
- [ ] (UMLS (CSP) C1536992) =Body Location or Region
|
- 25. APEH
- [This gene plays a role in the degradation of oxidatively-damaged proteins in living cells. ( NCI )] (UMLS (NCI) C1332101) APEH Gene;
N-Acylaminoacyl-Peptide Hydrolase Gene =Gene or Genome ;
| - 75. APO
- (UMLS (NCI) C0285452) =Therapeutic or Preventive Procedure ;
|
- 26. APEX Nuclease (Apurinic/Apyrimidinic Endonuclease) 2 Gene
- [This gene plays a role in DNA recognition and repair. ( NCI )] (UMLS (NCI) C1425157) APEX2;
APEX2 Gene =Gene or Genome | - 76. Apo B
- [structural proteins of chylomicrons, VLDL, and LDL; important in secretion and transport of lipoproteins; binding proteins for LDL receptor pathway. ( CSP )] (UMLS (CSP) C0003593) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 27. APEX Nuclease (Multifunctional DNA Repair Enzyme) 1 Gene
- [This gene is involved in DNA repair processes. ( NCI )] (UMLS (NCI) C1332102) APEX1;
APEX1 Gene =Gene or Genome ;
| - 77. Apo E
- [prominent protein constituents of plasma VLDL, chylomicrons, and a subfraction of HDL as well as of remnant lipoproteins which are derived from the lipoprotein lipase-mediated intravascular catabolism of triglyceride-rich lipoproteins; recognized by the LDL receptor and Apo E receptor; any defect in the Apo E metabolism leads to increased plasma Apo E levels; a strong association has been found between high levels of Apo E and type III hyperlipoproteinemia. ( CSP )] (UMLS (CSP) C0003595) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 28. APEX Nuclease-Like 2
- [Apurinic/apyrimidinic (AP) sites occur frequently in DNA molecules by spontaneous hydrolysis, by DNA damaging agents or by DNA glycosylases that remove specific abnormal bases. AP sites are pre-mutagenic lesions that can prevent normal DNA replication so the cell contains systems to identify and repair such sites. Class II AP endonucleases cleave the phosphodiester backbone 5' to the AP site. Apurinic/Apyrimidinic Endonuclease 2, a protein encoded by the APEXL2 gene, has a weak class II AP endonuclease activity. Most of this protein is located in the nucleus but some is also present in mitochondria. This protein may play an important role in both nuclear and mitochondrial base excision repair (BER). (From LocusLink 27301) ( NCI )] (UMLS (NCI) C1332330) APEXL2;
Apurinic/Apyrimidinic Endonuclease 2;
Apurinic/Apyrimidinic Endonuclease-Like 2 =Amino Acid, Peptide, or Protein; Enzyme | - 78. APO-1 Cell Surface Antigen
- [differentiation antigens expressed on a variety of cell lines; regulate peripheral immune responses. ( CSP )] (UMLS (NCI) C0245662) =Amino Acid, Peptide, or Protein; Immunologic Factor; Receptor =CD antigen;
|
- 29. Apex of the Heart
- (UMLS (NCI) C0225811) =Body Location or Region
| - 79. APO1 antigen
- [ ] (UMLS (CSP) C0599661) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
|
- 30. Apex of the Lung
- (UMLS (NCI) C0225703) =Body Location or Region
| - 80. APO2 Ligand
- [Tumor Necrosis Factor Ligand Superfamily Member 10, encoded by the TNFSF10 Gene, is a homotrimeric type II membrane protein that rapidly induces oligomerization of receptor intracellular death domains and apoptosis in a variety of cells. It preferentially induces apoptosis in transformed and tumor cells, but does not appear to kill normal cells although it is expressed at a significant level in most normal tissues. This protein binds to several members of TNF receptor superfamily including TNFRSF10A/TRAILR1, TNFRSF10B/TRAILR2, TNFRSF10C/TRAILR3, TNFRSF10D/TRAILR4, and possibly also to TNFRSF11B/OPG. The activity of this protein may be modulated by binding to the decoy receptors TNFRSF10C/TRAILR3, TNFRSF10D/TRAILR4, and TNFRSF11B/OPG that cannot induce apoptosis. The binding of this protein to its receptors has been shown to trigger the activation of MAPK8/JNK, caspase 8, and caspase 3. (From LocusLink, OMIM and NCI) ( NCI )] (UMLS (NCI) C0385242) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 31. Apex of the Prostate
- [THe uppermost part of the prostate gland. ( NCI )] (UMLS (NCI) C0227959) =Body Part, Organ, or Organ Component
| - 81. Apocrine Adenoma
- [A benign epithelial neoplasm arising from the apocrine sweat glands. Representative examples include tubular apocrine adenoma and external auditory canal ceruminous adenoma. ( NCI )] (UMLS (NCI) C0334345) =Neoplastic Process
|
- 32. Apex of the Tongue
- (UMLS (NCI) C0226946) =Body Location or Region
| - 82. Apocrine Adenosis of Breast
- (UMLS (NCI) C1332314) Apocrine Adenosis of the Breast;
Breast Apocrine Adenosis;
=Disease or Syndrome ;
|
- 33. APEXCARDIOGRAM
- [ ] (UMLS (ICD9CM) C0199612) =Diagnostic Procedure
| - 83. Apocrine Breast Carcinoma
- [An adenocarcinoma of the breast characterized by the presence of two intermingled cellular components: cells with abundant granular, eosinophilic cytoplasm, and cells with abundant cytoplasm containing fine empty vacuoles. ( NCI )] (UMLS (NCI) C1332316) Apocrine Carcinoma of Breast;
Apocrine Carcinoma of the Breast;
Breast Apocrine Carcinoma =Neoplastic Process ;
|
- 34. Apha-((ethylamino)methyl)-3-hydroxybenzenemethanol
- [An adrenergic agonist with vasoconstrictive activity. Etilefrine selectively binds to and activates alpha-1-adrenergic receptors of the arteriolar and venous vasculature. This causes smooth muscle contraction and leads to a decrease in venous pooling and increase in blood pressure. This agent may also stimulate beta-1 adrenergic receptors, leading to positive chronotropic and inotropic effects. ( NCI )] (UMLS (NCI) C0015116) =Organic Chemical; Pharmacologic Substance ;
| - 84. Apocrine Breast Carcinoma In Situ
- (UMLS (NCI) C1332315) Apocrine Carcinoma in situ of Breast;
Apocrine Carcinoma in situ of the Breast;
Breast Apocrine Carcinoma in situ =Neoplastic Process ;
|
- 35. APHAKIA
- [Absence of crystalline lens totally or partially from field of vision, from any cause except after cataract extraction. Aphakia is mainly congenital or as result of LENS DISLOCATION AND SUBLUXATION. ( MSH )] (UMLS (ICD9CM) C0003534) =Anatomical Abnormality ;
| - 85. Apocrine Metaplasia
- (UMLS (NCI) C0334036) =Neoplastic Process
|
- 36. Aphakia and other disorders of lens
- [ ] (UMLS (ICD9CM) C0155371) =Disease or Syndrome ;
| - 86. Apocrine Metaplasia of Breast
- (UMLS (NCI) C0269252) =Disease or Syndrome
|
- 37. aphasia
- [cognitive disorder marked by an impaired ability to comprehend or express language in its written or spoken form; caused by diseases which affect the language areas of the dominant hemisphere; general categories include receptive, expressive, and mixed forms of aphasia. ( CSP )] (UMLS (CSP) C0003537) =Mental or Behavioral Dysfunction ;
| - 87. Apocrine Neoplasm
- (UMLS (NCI) C1332318) Apocrine Neoplasm of Skin;
Apocrine Neoplasm of the Skin;
Apocrine Skin Neoplasm;
Apocrine Skin Tumor;
Apocrine Tumor;
Apocrine Tumor of Skin;
Apocrine Tumor of the Skin =Neoplastic Process ;
|
- 38. Aphasia as late effect of cerebrovascular disease
- [ ] (UMLS (ICD9CM) C0489985) =Mental or Behavioral Dysfunction ;
| - 88. Apocrine Sweat Gland
- (UMLS (NCI) C0930083) =Body Part, Organ, or Organ Component
|
- 39. aphemia
- [ ] (UMLS (CSP) C0597893) =Mental or Behavioral Dysfunction
| - 89. Apocrine Sweat Gland Hamartoma
- (UMLS (NCI) C1332319) Hamartoma of Apocrine Sweat Gland;
Hamartoma of the Apocrine Sweat Gland;
=Disease or Syndrome ;
|
- 40. apheresis
- [(fer-E-sis) A procedure in which blood is collected, part of the blood such as platelets or white blood cells is taken out, and the rest of the blood is returned to the donor. ( NCI )] (UMLS (NCI) C0005791) =Therapeutic or Preventive Procedure ;
| - 90. Apoda
- [ ] (UMLS (CSP) C0597830) =Amphibian
|
- 41. aphidicolin
- [terpenoid compound from the fungus Cephalosporium amphidicola which inhibits eukaryotic, alpha-type DNA polymerases; used in tissue culture to synchronize cell division; derivatives are potential antineoplastic and antiAIDS agents. ( CSP )] (UMLS (CSP) C0085171) =Organic Chemical; Pharmacologic Substance =antimetabolite;
| - 91. apoenzyme
- [protein components of the enzyme minus any cofactors or prosthetic groups that might be required for the enzyme to be catalytically functional. ( CSP )] (UMLS (CSP) C0003589) =Amino Acid, Peptide, or Protein; Enzyme
|
- 42. APHONIA
- [Complete loss of phonation due to organic disease of the larynx or to nonorganic (i.e., psychogenic) causes. ( MSH )] (UMLS (ICD9CM) C0003564) =Sign or Symptom ;
| - 92. apolipoprotein
- [protein components of lipoproteins which remain after the lipids to which the proteins are bound have been removed; they play an important role in lipid transport and metabolism. ( CSP )] (UMLS (CSP) C0003591) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 43. aphthous stomatitis
- [recurrent disease of the oral mucosa of unknown etiology, characterized by small white ulcerative lesions lasting 7 to 14 days. ( CSP )] (UMLS (CSP) C0038363) =Disease or Syndrome ;
=skin ulcer;
stomatitis | - 93. apolipoprotein J
- [a widely distributed glycoprotein with a diverse set of biologic actions, the most prominent of which is its ability to promote cell interactions; another unique feature is its induction at times of tissue injury and remodeling. ( CSP )] (UMLS (CSP) C0055966) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
=apolipoprotein;
glycoprotein |
- 44. Aphthovirus
- [A genus of the family PICORNAVIRIDAE infecting mainly cloven-hoofed animals. They cause vesicular lesions and upper respiratory tract infections. FOOT AND MOUTH DISEASE VIRUS is the type species. ( MSH )] (UMLS (CSP) C0016515) =Virus ;
| - 94. Apolizumab/Rituximab
- (UMLS (NCI) C1134497) =Therapeutic or Preventive Procedure
|
- 45. API 20 Strep
- [Identification, API 20 Strep ( HL7V3.0 )] (UMLS (HL7) C1553129) =Laboratory Procedure =ObservationMethod;
| - 95. Apollon
- [Baculoviral IAP Repeat-Containing Protein 6, encoded by the BIRC6 gene, is a member of the IAP (inhibitors of apoptosis proteins) family and the ubiquitin-conjugating enzyme family. This protein is expressed as a 530-kD protein in gliomas and ovarian cancers. BIRC6 may protect cancer cells from undergoing apoptosis and resist to apoptosis in the presence of anticancer drugs. BIRC6 contains a 70-amino acid cysteine- and histidine-rich baculovirus IAP repeat (BIR) and a zinc-binding RING finger. ( NCI )] (UMLS (NCI) C0910612) Baculoviral IAP Repeat-Containing Protein 6;
BIRC6;
KIAA1289;
=Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 46. API 20A
- [Identification, API 20A ( HL7V3.0 )] (UMLS (HL7) C1553130) =Laboratory Procedure =ObservationMethod;
| - 96. Apomine
- (UMLS (NCI) C0919349) =Organic Chemical; Pharmacologic Substance ;
|
- 47. API 20C AUX
- [Identification, API 20C AUX ( HL7V3.0 )] (UMLS (HL7) C1553131) =Laboratory Procedure =ObservationMethod;
| - 97. apomorphine
- [derivative of morphine that is a dopamine D2 agonist; a powerful emetic useful in acute poisoning; has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use. ( CSP )] (UMLS (CSP) C0003596) =Organic Chemical; Pharmacologic Substance
|
- 48. API 20E
- [Identification, API 20E ( HL7V3.0 )] (UMLS (HL7) C1553132) =Laboratory Procedure =ObservationMethod;
| - 98. Aponeurosis
- (UMLS (NCI) C0225205) =Tissue
|
- 49. API 20NE
- [Identification, API 20NE ( HL7V3.0 )] (UMLS (HL7) C1553133) =Laboratory Procedure =ObservationMethod;
| - 99. Apopain
- [Caspase-3, encoded by the CASP3 gene, is a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce 2 subunits, large and small, that dimerize to form the active enzyme. Caspase-3 is a central player in mediating apoptosis and is the most widely studied caspase. This protein cleaves and activates caspases 6, 7 and 9, and itself can be processed by caspases 8, 9 and 10. It is the predominant caspase involved in the cleavage of amyloid-beta 4A precursor protein, which is associated with neuronal death in Alzheimer's disease. Alternative splicing of the CASP3 gene results in two transcript variants which encode the same protein. (From LocusLink and NCI) ( NCI )] (UMLS (NCI) C0291573) =Amino Acid, Peptide, or Protein; Enzyme
|
- 50. API 50 CH
- [Identification, API 50 CH ( HL7V3.0 )] (UMLS (HL7) C1553134) =Laboratory Procedure =ObservationMethod;
| - 100. apophysis ossium
- [ ] (UMLS (CSP) C0872099) =Body Part, Organ, or Organ Component ;
|
home
